Jazz Pharmaceuticals plc buy Morgan Stanley
Start price
06.08.25
/
50%
€92.16
Target price
06.08.26
€140.03
Performance (%)
18.54%
Price
01.09.25
€109.25
Summary
This prediction is currently active. The prediction currently has a performance of 18.54%. This prediction currently runs until 06.08.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Jazz Pharmaceuticals plc | 1.817% |
| iShares Core DAX® | -0.940% |
| iShares Nasdaq 100 | -0.726% |
| iShares Nikkei 225® | -0.767% |
| iShares S&P 500 | -0.345% |
Comments by Morgan_Stanley for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) had its price target lowered by analysts at Morgan Stanley from $165.00 to $162.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Morgan_Stanley for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€107.95
28.08.25
28.08.25
-
28.08.26
28.08.26
1.20%
01.09.25
01.09.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€99.04
22.07.25
22.07.25
€141.14
22.07.26
22.07.26
10.31%
01.09.25
01.09.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€90.20
07.05.25
07.05.25
€146.33
07.05.26
07.05.26
21.12%
01.09.25
01.09.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€128.00
07.03.25
07.03.25
€168.73
07.03.26
07.03.26
-14.65%
01.09.25
01.09.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€120.35
12.12.24
12.12.24
€167.02
12.12.25
12.12.25
-9.22%
01.09.25
01.09.25